32 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Is a Beat in Store for Perrigo (PRGO) This Earnings Season? http://www.zacks.com/stock/news/891904/is-a-beat-in-store-for-perrigo-prgo-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-891904 Apr 27, 2020 - Perrigo's (PRGO) Consumer Self Care Americas segment is expected to have aided the company's top line in the soon-to-be-reported quarter.
2 Crazy-Cheap Buffett Stocks to Buy Now https://www.fool.com/investing/2020/04/13/2-crazy-cheap-buffett-stocks-to-buy-now.aspx?source=iedfolrf0000001 Apr 13, 2020 - Berkshire Hathaway and Teva Pharmaceutical Industries Ltd. are absurdly cheap right now.
Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know http://www.zacks.com/stock/news/859627/teva-pharmaceutical-industries-ltd-teva-gains-as-market-dips-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-859627 Apr 07, 2020 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $9.54 in the latest trading session, marking a +0.85% move from the prior day.
UBS still bullish on Teva despite trimming fair value target; shares up 9% https://seekingalpha.com/news/3558659-ubs-still-bullish-on-teva-despite-trimming-fair-value-target-shares-up-9?source=feed_sector_healthcare Apr 06, 2020 - In a note, UBS reiterates its Buy rating on Teva Pharmaceutical Industries (TEVA +8.5%) albeit with a revised price target of $12 (from $14).Analyst Kevin Caliendo believes the company is relatively i
3 Warren Buffett Stocks I Absolutely, Positively Wouldn't Buy Right Now https://www.fool.com/investing/2020/04/05/3-warren-buffett-stocks-i-absolutely-positively-wo.aspx?source=iedfolrf0000001 Apr 05, 2020 - The Oracle of Omaha owns some fantastic stocks in his Berkshire Hathaway portfolio. These aren't in the group.
Teva prevails in migraine patent dispute with Lilly; shares up 9% https://seekingalpha.com/news/3556858-teva-prevails-in-migraine-patent-dispute-lilly-shares-up-9?utm_source=feed_news_all&utm_medium=referral Mar 31, 2020 - The USPTO's Patent Trial and Appeal Board has upheld three patents protecting Teva Pharmaceutical Industries' (TEVA +9.0%) migraine med Ajovy (fremanezumab-vfrm) that were challenged by Eli Lilly (LLY
Teva prevails in migraine patent dispute; shares up 9% https://seekingalpha.com/news/3556858-teva-prevails-in-migraine-patent-dispute-shares-up-9?source=feed_sector_healthcare Mar 31, 2020 - The USPTO's Patent Trial and Appeal Board has upheld three patents protecting Teva Pharmaceutical Industries' (TEVA +9.0%) migraine med Ajovy (fremanezumab-vfrm) that were challenged by Eli Lilly (LLY
3 Ridiculously Cheap Buffett Stocks to Buy Now https://www.fool.com/investing/2020/03/31/3-ridiculously-cheap-buffett-stocks-to-buy-now.aspx?source=iedfolrf0000001 Mar 31, 2020 - It's been a while since the Oracle of Omaha had bargains like this in his portfolio.
FDA Authorizes Use of Old Malaria Drugs to Treat COVID-19 https://www.fool.com/investing/2020/03/30/fda-authorizes-use-of-old-malaria-drugs-to-treat-c.aspx?source=iedfolrf0000001 Mar 30, 2020 - Despite scant clinical evidence that they work, the FDA issued its first emergency use authorization for therapeutic products to treat the novel coronavirus.
Novartis Reports Data on Inclisiran, CHMP Positive on Zolgensma http://www.zacks.com/stock/news/845181/novartis-reports-data-on-inclisiran-chmp-positive-on-zolgensma?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-845181 Mar 30, 2020 - Novartis (NVS) announces pipeline updates on inclisiran and regulatory updates on Cosentyx and Zolgensma.

Pages: 1234

<<<Page 3